APO Research

APO RESEARCH · REPORT

Inhaled Nitric Oxide Delivery Device

Selected research

Market Analysis & Forecast

Global Inhaled Nitric Oxide Delivery Device Market Analysis and Forecast 2026-2032

Market perspective

The global Inhaled Nitric Oxide Delivery Device market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Inhaled Nitric Oxide Delivery Device is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Inhaled Nitric Oxide Delivery Device is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Inhaled Nitric Oxide Delivery Device is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Inhaled Nitric Oxide Delivery Device is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Inhaled Nitric Oxide Delivery Device include Air Liquide Healthcare, Bellerophon Therapeutics, Beyond Air, Circassia Pharmaceuticals, Getinge, LINDE, Mallinckrodt Pharmaceuticals, NU MED and Praxair Technology Inc., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Inhaled Nitric Oxide Delivery Device, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Inhaled Nitric Oxide Delivery Device, also provides the sales of main regions and countries. Of the upcoming market potential for Inhaled Nitric Oxide Delivery Device, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Inhaled Nitric Oxide Delivery Device sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Inhaled Nitric Oxide Delivery Device market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Inhaled Nitric Oxide Delivery Device sales, projected growth trends, production technology, application and end-user industry.

Inhaled Nitric Oxide Delivery Device Segment by Company

Air Liquide Healthcare

Bellerophon Therapeutics

Beyond Air

Circassia Pharmaceuticals

Getinge

LINDE

Mallinckrodt Pharmaceuticals

NU MED

Praxair Technology Inc.

Vero Biotech

Inhaled Nitric Oxide Delivery Device Segment by Type

Inhaled Nitric Oxide Delivery Device for Children

Inhaled Nitric Oxide Delivery Device for Adults

Inhaled Nitric Oxide Delivery Device Segment by Application

Hypoxic Respiratory Failure (HRF)

Chronic Obstructive Pulmonary Disease (COPD)

Acute Hypoxemic Respiratory Failure (AHRF)

Others

Inhaled Nitric Oxide Delivery Device Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Inhaled Nitric Oxide Delivery Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Inhaled Nitric Oxide Delivery Device and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Inhaled Nitric Oxide Delivery Device.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Inhaled Nitric Oxide Delivery Device in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Inhaled Nitric Oxide Delivery Device manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Inhaled Nitric Oxide Delivery Device sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Inhaled Nitric Oxide Delivery Device Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Inhaled Nitric Oxide Delivery Device for Children Major Manufacturers Table 3. Inhaled Nitric Oxide Delivery Device for Adults Major Manufacturers Table 4. Global Inhaled Nitric Oxide Delivery Device Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hypoxic Respiratory Failure (HRF) Major Manufacturers Table 6. Chronic Obstructive Pulmonary Disease (COPD) Major Manufacturers Table 7. Acute Hypoxemic Respiratory Failure (AHRF) Major Manufacturers Table 8. Others Major Manufacturers Table 9. Inhaled Nitric Oxide Delivery Device Industry Trends Table 10. Inhaled Nitric Oxide Delivery Device Industry Drivers Table 11. Inhaled Nitric Oxide Delivery Device Industry Opportunities and Challenges Table 12. Inhaled Nitric Oxide Delivery Device Industry Restraints Table 13. Global Inhaled Nitric Oxide Delivery Device Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Inhaled Nitric Oxide Delivery Device Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Inhaled Nitric Oxide Delivery Device Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Region (2021-2026) Table 17. Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Region (2027-2032) Table 18. Global Inhaled Nitric Oxide Delivery Device Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 19. Global Inhaled Nitric Oxide Delivery Device Sales by Region (2021-2026) & (k units) Table 20. Global Inhaled Nitric Oxide Delivery Device Sales by Region (2027-2032) & (k units) Table 21. Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Region (2021-2026) Table 22. Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Region (2027-2032) Table 23. Global Inhaled Nitric Oxide Delivery Device Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Inhaled Nitric Oxide Delivery Device Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Manufacturers (2021-2026) Table 27. Global Inhaled Nitric Oxide Delivery Device Sales Price (USD/unit) of Manufacturers (2021-2026) Table 28. Global Inhaled Nitric Oxide Delivery Device Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Inhaled Nitric Oxide Delivery Device Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Inhaled Nitric Oxide Delivery Device Manufacturers, Product Type & Application Table 31. Global Inhaled Nitric Oxide Delivery Device Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Inhaled Nitric Oxide Delivery Device by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Inhaled Nitric Oxide Delivery Device Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Inhaled Nitric Oxide Delivery Device Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Inhaled Nitric Oxide Delivery Device Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Type (2021-2026) Table 38. Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Type (2027-2032) Table 39. Global Inhaled Nitric Oxide Delivery Device Sales by Type 2021 VS 2025 VS 2032 (k units) Table 40. Global Inhaled Nitric Oxide Delivery Device Sales by Type (2021-2026) & (k units) Table 41. Global Inhaled Nitric Oxide Delivery Device Sales by Type (2027-2032) & (k units) Table 42. Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Type (2021-2026) Table 43. Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Type (2027-2032) Table 44. Global Inhaled Nitric Oxide Delivery Device Price by Type (2021-2026) & (USD/unit) Table 45. Global Inhaled Nitric Oxide Delivery Device Price by Type (2027-2032) & (USD/unit) Table 46. Global Inhaled Nitric Oxide Delivery Device Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Inhaled Nitric Oxide Delivery Device Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Inhaled Nitric Oxide Delivery Device Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Application (2021-2026) Table 50. Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Application (2027-2032) Table 51. Global Inhaled Nitric Oxide Delivery Device Sales by Application 2021 VS 2025 VS 2032 (k units) Table 52. Global Inhaled Nitric Oxide Delivery Device Sales by Application (2021-2026) & (k units) Table 53. Global Inhaled Nitric Oxide Delivery Device Sales by Application (2027-2032) & (k units) Table 54. Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Application (2021-2026) Table 55. Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Application (2027-2032) Table 56. Global Inhaled Nitric Oxide Delivery Device Price by Application (2021-2026) & (USD/unit) Table 57. Global Inhaled Nitric Oxide Delivery Device Price by Application (2027-2032) & (USD/unit) Table 58. Air Liquide Healthcare Company Information Table 59. Air Liquide Healthcare Business Overview Table 60. Air Liquide Healthcare Inhaled Nitric Oxide Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 61. Air Liquide Healthcare Inhaled Nitric Oxide Delivery Device Product Portfolio Table 62. Air Liquide Healthcare Recent Development Table 63. Bellerophon Therapeutics Company Information Table 64. Bellerophon Therapeutics Business Overview Table 65. Bellerophon Therapeutics Inhaled Nitric Oxide Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 66. Bellerophon Therapeutics Inhaled Nitric Oxide Delivery Device Product Portfolio Table 67. Bellerophon Therapeutics Recent Development Table 68. Beyond Air Company Information Table 69. Beyond Air Business Overview Table 70. Beyond Air Inhaled Nitric Oxide Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 71. Beyond Air Inhaled Nitric Oxide Delivery Device Product Portfolio Table 72. Beyond Air Recent Development Table 73. Circassia Pharmaceuticals Company Information Table 74. Circassia Pharmaceuticals Business Overview Table 75. Circassia Pharmaceuticals Inhaled Nitric Oxide Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 76. Circassia Pharmaceuticals Inhaled Nitric Oxide Delivery Device Product Portfolio Table 77. Circassia Pharmaceuticals Recent Development Table 78. Getinge Company Information Table 79. Getinge Business Overview Table 80. Getinge Inhaled Nitric Oxide Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 81. Getinge Inhaled Nitric Oxide Delivery Device Product Portfolio Table 82. Getinge Recent Development Table 83. LINDE Company Information Table 84. LINDE Business Overview Table 85. LINDE Inhaled Nitric Oxide Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 86. LINDE Inhaled Nitric Oxide Delivery Device Product Portfolio Table 87. LINDE Recent Development Table 88. Mallinckrodt Pharmaceuticals Company Information Table 89. Mallinckrodt Pharmaceuticals Business Overview Table 90. Mallinckrodt Pharmaceuticals Inhaled Nitric Oxide Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Mallinckrodt Pharmaceuticals Inhaled Nitric Oxide Delivery Device Product Portfolio Table 92. Mallinckrodt Pharmaceuticals Recent Development Table 93. NU MED Company Information Table 94. NU MED Business Overview Table 95. NU MED Inhaled Nitric Oxide Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. NU MED Inhaled Nitric Oxide Delivery Device Product Portfolio Table 97. NU MED Recent Development Table 98. Praxair Technology Inc. Company Information Table 99. Praxair Technology Inc. Business Overview Table 100. Praxair Technology Inc. Inhaled Nitric Oxide Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Praxair Technology Inc. Inhaled Nitric Oxide Delivery Device Product Portfolio Table 102. Praxair Technology Inc. Recent Development Table 103. Vero Biotech Company Information Table 104. Vero Biotech Business Overview Table 105. Vero Biotech Inhaled Nitric Oxide Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Vero Biotech Inhaled Nitric Oxide Delivery Device Product Portfolio Table 107. Vero Biotech Recent Development Table 108. North America Inhaled Nitric Oxide Delivery Device Revenue by Type (2021-2026) & (US$ Million) Table 109. North America Inhaled Nitric Oxide Delivery Device Revenue by Type (2027-2032) & (US$ Million) Table 110. North America Inhaled Nitric Oxide Delivery Device Sales by Type (2021-2026) & (k units) Table 111. North America Inhaled Nitric Oxide Delivery Device Sales by Type (2027-2032) & (k units) Table 112. North America Inhaled Nitric Oxide Delivery Device Sales Price by Type (2021-2026) & (USD/unit) Table 113. North America Inhaled Nitric Oxide Delivery Device Sales Price by Type (2027-2032) & (USD/unit) Table 114. North America Inhaled Nitric Oxide Delivery Device Revenue by Application (2021-2026) & (US$ Million) Table 115. North America Inhaled Nitric Oxide Delivery Device Revenue by Application (2027-2032) & (US$ Million) Table 116. North America Inhaled Nitric Oxide Delivery Device Sales by Application (2021-2026) & (k units) Table 117. North America Inhaled Nitric Oxide Delivery Device Sales by Application (2027-2032) & (k units) Table 118. North America Inhaled Nitric Oxide Delivery Device Sales Price by Application (2021-2026) & (USD/unit) Table 119. North America Inhaled Nitric Oxide Delivery Device Sales Price by Application (2027-2032) & (USD/unit) Table 120. North America Inhaled Nitric Oxide Delivery Device Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 121. North America Inhaled Nitric Oxide Delivery Device Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 122. North America Inhaled Nitric Oxide Delivery Device Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 123. North America Inhaled Nitric Oxide Delivery Device Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 124. North America Inhaled Nitric Oxide Delivery Device Sales by Country (2021-2026) & (k units) Table 125. North America Inhaled Nitric Oxide Delivery Device Sales by Country (2027-2032) & (k units) Table 126. North America Inhaled Nitric Oxide Delivery Device Sales Price by Country (2021-2026) & (USD/unit) Table 127. North America Inhaled Nitric Oxide Delivery Device Sales Price by Country (2027-2032) & (USD/unit) Table 128. United States Inhaled Nitric Oxide Delivery Device Revenue (2021-2032) & (US$ Million) Table 129. Canada Inhaled Nitric Oxide Delivery Device Revenue (2021-2032) & (US$ Million) Table 130. Mexico Inhaled Nitric Oxide Delivery Device Revenue (2021-2032) & (US$ Million) Table 131. Europe Inhaled Nitric Oxide Delivery Device Revenue by Type (2021-2026) & (US$ Million) Table 132. Europe Inhaled Nitric Oxide Delivery Device Revenue by Type (2027-2032) & (US$ Million) Table 133. Europe Inhaled Nitric Oxide Delivery Device Sales by Type (2021-2026) & (k units) Table 134. Europe Inhaled Nitric Oxide Delivery Device Sales by Type (2027-2032) & (k units) Table 135. Europe Inhaled Nitric Oxide Delivery Device Sales Price by Type (2021-2026) & (USD/unit) Table 136. Europe Inhaled Nitric Oxide Delivery Device Sales Price by Type (2027-2032) & (USD/unit) Table 137. Europe Inhaled Nitric Oxide Delivery Device Revenue by Application (2021-2026) & (US$ Million) Table 138. Europe Inhaled Nitric Oxide Delivery Device Revenue by Application (2027-2032) & (US$ Million) Table 139. Europe Inhaled Nitric Oxide Delivery Device Sales by Application (2021-2026) & (k units) Table 140. Europe Inhaled Nitric Oxide Delivery Device Sales by Application (2027-2032) & (k units) Table 141. Europe Inhaled Nitric Oxide Delivery Device Sales Price by Application (2021-2026) & (USD/unit) Table 142. Europe Inhaled Nitric Oxide Delivery Device Sales Price by Application (2027-2032) & (USD/unit) Table 143. Europe Inhaled Nitric Oxide Delivery Device Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 144. Europe Inhaled Nitric Oxide Delivery Device Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 145. Europe Inhaled Nitric Oxide Delivery Device Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 146. Europe Inhaled Nitric Oxide Delivery Device Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 147. Europe Inhaled Nitric Oxide Delivery Device Sales by Country (2021-2026) & (k units) Table 148. Europe Inhaled Nitric Oxide Delivery Device Sales by Country (2027-2032) & (k units) Table 149. Europe Inhaled Nitric Oxide Delivery Device Sales Price by Country (2021-2026) & (USD/unit) Table 150. Europe Inhaled Nitric Oxide Delivery Device Sales Price by Country (2027-2032) & (USD/unit) Table 151. Germany Inhaled Nitric Oxide Delivery Device Revenue (2021-2032) & (US$ Million) Table 152. France Inhaled Nitric Oxide Delivery Device Revenue (2021-2032) & (US$ Million) Table 153. U.K. Inhaled Nitric Oxide Delivery Device Revenue (2021-2032) & (US$ Million) Table 154. Italy Inhaled Nitric Oxide Delivery Device Revenue (2021-2032) & (US$ Million) Table 155. Russia Inhaled Nitric Oxide Delivery Device Revenue (2021-2032) & (US$ Million) Table 156. Spain Inhaled Nitric Oxide Delivery Device Revenue (2021-2032) & (US$ Million) Table 157. Netherlands Inhaled Nitric Oxide Delivery Device Revenue (2021-2032) & (US$ Million) Table 158. Switzerland Inhaled Nitric Oxide Delivery Device Revenue (2021-2032) & (US$ Million) Table 159. Sweden Inhaled Nitric Oxide Delivery Device Revenue (2021-2032) & (US$ Million) Table 160. Poland Inhaled Nitric Oxide Delivery Device Revenue (2021-2032) & (US$ Million) Table 161. China Inhaled Nitric Oxide Delivery Device Revenue by Type (2021-2026) & (US$ Million) Table 162. China Inhaled Nitric Oxide Delivery Device Revenue by Type (2027-2032) & (US$ Million) Table 163. China Inhaled Nitric Oxide Delivery Device Sales by Type (2021-2026) & (k units) Table 164. China Inhaled Nitric Oxide Delivery Device Sales by Type (2027-2032) & (k units) Table 165. China Inhaled Nitric Oxide Delivery Device Sales Price by Type (2021-2026) & (USD/unit) Table 166. China Inhaled Nitric Oxide Delivery Device Sales Price by Type (2027-2032) & (USD/unit) Table 167. China Inhaled Nitric Oxide Delivery Device Revenue by Application (2021-2026) & (US$ Million) Table 168. China Inhaled Nitric Oxide Delivery Device Revenue by Application (2027-2032) & (US$ Million) Table 169. China Inhaled Nitric Oxide Delivery Device Sales by Application (2021-2026) & (k units) Table 170. China Inhaled Nitric Oxide Delivery Device Sales by Application (2027-2032) & (k units) Table 171. China Inhaled Nitric Oxide Delivery Device Sales Price by Application (2021-2026) & (USD/unit) Table 172. China Inhaled Nitric Oxide Delivery Device Sales Price by Application (2027-2032) & (USD/unit) Table 173. Asia Inhaled Nitric Oxide Delivery Device Revenue by Type (2021-2026) & (US$ Million) Table 174. Asia Inhaled Nitric Oxide Delivery Device Revenue by Type (2027-2032) & (US$ Million) Table 175. Asia Inhaled Nitric Oxide Delivery Device Sales by Type (2021-2026) & (k units) Table 176. Asia Inhaled Nitric Oxide Delivery Device Sales by Type (2027-2032) & (k units) Table 177. Asia Inhaled Nitric Oxide Delivery Device Sales Price by Type (2021-2026) & (USD/unit) Table 178. Asia Inhaled Nitric Oxide Delivery Device Sales Price by Type (2027-2032) & (USD/unit) Table 179. Asia Inhaled Nitric Oxide Delivery Device Revenue by Application (2021-2026) & (US$ Million) Table 180. Asia Inhaled Nitric Oxide Delivery Device Revenue by Application (2027-2032) & (US$ Million) Table 181. Asia Inhaled Nitric Oxide Delivery Device Sales by Application (2021-2026) & (k units) Table 182. Asia Inhaled Nitric Oxide Delivery Device Sales by Application (2027-2032) & (k units) Table 183. Asia Inhaled Nitric Oxide Delivery Device Sales Price by Application (2021-2026) & (USD/unit) Table 184. Asia Inhaled Nitric Oxide Delivery Device Sales Price by Application (2027-2032) & (USD/unit) Table 185. Asia Inhaled Nitric Oxide Delivery Device Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 186. Asia Inhaled Nitric Oxide Delivery Device Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 187. Asia Inhaled Nitric Oxide Delivery Device Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 188. Asia Inhaled Nitric Oxide Delivery Device Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 189. Asia Inhaled Nitric Oxide Delivery Device Sales by Country (2021-2026) & (k units) Table 190. Asia Inhaled Nitric Oxide Delivery Device Sales by Country (2027-2032) & (k units) Table 191. Asia Inhaled Nitric Oxide Delivery Device Sales Price by Country (2021-2026) & (USD/unit) Table 192. Asia Inhaled Nitric Oxide Delivery Device Sales Price by Country (2027-2032) & (USD/unit) Table 193. Japan Inhaled Nitric Oxide Delivery Device Revenue (2021-2032) & (US$ Million) Table 194. South Korea Inhaled Nitric Oxide Delivery Device Revenue (2021-2032) & (US$ Million) Table 195. India Inhaled Nitric Oxide Delivery Device Revenue (2021-2032) & (US$ Million) Table 196. Australia Inhaled Nitric Oxide Delivery Device Revenue (2021-2032) & (US$ Million) Table 197. Taiwan Inhaled Nitric Oxide Delivery Device Revenue (2021-2032) & (US$ Million) Table 198. Southeast Asia Inhaled Nitric Oxide Delivery Device Revenue (2021-2032) & (US$ Million) Table 199. SAMEA Inhaled Nitric Oxide Delivery Device Revenue by Type (2021-2026) & (US$ Million) Table 200. SAMEA Inhaled Nitric Oxide Delivery Device Revenue by Type (2027-2032) & (US$ Million) Table 201. SAMEA Inhaled Nitric Oxide Delivery Device Sales by Type (2021-2026) & (k units) Table 202. SAMEA Inhaled Nitric Oxide Delivery Device Sales by Type (2027-2032) & (k units) Table 203. SAMEA Inhaled Nitric Oxide Delivery Device Sales Price by Type (2021-2026) & (USD/unit) Table 204. SAMEA Inhaled Nitric Oxide Delivery Device Sales Price by Type (2027-2032) & (USD/unit) Table 205. SAMEA Inhaled Nitric Oxide Delivery Device Revenue by Application (2021-2026) & (US$ Million) Table 206. SAMEA Inhaled Nitric Oxide Delivery Device Revenue by Application (2027-2032) & (US$ Million) Table 207. SAMEA Inhaled Nitric Oxide Delivery Device Sales by Application (2021-2026) & (k units) Table 208. SAMEA Inhaled Nitric Oxide Delivery Device Sales by Application (2027-2032) & (k units) Table 209. SAMEA Inhaled Nitric Oxide Delivery Device Sales Price by Application (2021-2026) & (USD/unit) Table 210. SAMEA Inhaled Nitric Oxide Delivery Device Sales Price by Application (2027-2032) & (USD/unit) Table 211. SAMEA Inhaled Nitric Oxide Delivery Device Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 212. SAMEA Inhaled Nitric Oxide Delivery Device Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 213. SAMEA Inhaled Nitric Oxide Delivery Device Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 214. SAMEA Inhaled Nitric Oxide Delivery Device Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 215. SAMEA Inhaled Nitric Oxide Delivery Device Sales by Country (2021-2026) & (k units) Table 216. SAMEA Inhaled Nitric Oxide Delivery Device Sales by Country (2027-2032) & (k units) Table 217. SAMEA Inhaled Nitric Oxide Delivery Device Sales Price by Country (2021-2026) & (USD/unit) Table 218. SAMEA Inhaled Nitric Oxide Delivery Device Sales Price by Country (2027-2032) & (USD/unit) Table 219. Brazil Inhaled Nitric Oxide Delivery Device Revenue (2021-2032) & (US$ Million) Table 220. Argentina Inhaled Nitric Oxide Delivery Device Revenue (2021-2032) & (US$ Million) Table 221. Chile Inhaled Nitric Oxide Delivery Device Revenue (2021-2032) & (US$ Million) Table 222. Colombia Inhaled Nitric Oxide Delivery Device Revenue (2021-2032) & (US$ Million) Table 223. Peru Inhaled Nitric Oxide Delivery Device Revenue (2021-2032) & (US$ Million) Table 224. Saudi Arabia Inhaled Nitric Oxide Delivery Device Revenue (2021-2032) & (US$ Million) Table 225. Israel Inhaled Nitric Oxide Delivery Device Revenue (2021-2032) & (US$ Million) Table 226. UAE Inhaled Nitric Oxide Delivery Device Revenue (2021-2032) & (US$ Million) Table 227. Turkey Inhaled Nitric Oxide Delivery Device Revenue (2021-2032) & (US$ Million) Table 228. Iran Inhaled Nitric Oxide Delivery Device Revenue (2021-2032) & (US$ Million) Table 229. Egypt Inhaled Nitric Oxide Delivery Device Revenue (2021-2032) & (US$ Million) Table 230. Key Raw Materials Table 231. Raw Materials Key Suppliers Table 232. Inhaled Nitric Oxide Delivery Device Distributors List Table 233. Inhaled Nitric Oxide Delivery Device Customers List Table 234. Research Programs/Design for This Report Table 235. Authors List of This Report Table 236. Secondary Sources Table 237. Primary Sources List of Figures Figure 1. Inhaled Nitric Oxide Delivery Device Image Figure 2. Global Inhaled Nitric Oxide Delivery Device Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Inhaled Nitric Oxide Delivery Device Market Size Share 2021 VS 2025 VS 2032 Figure 4. Inhaled Nitric Oxide Delivery Device for Children Image Figure 5. Inhaled Nitric Oxide Delivery Device for Adults Image Figure 6. Global Inhaled Nitric Oxide Delivery Device Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Inhaled Nitric Oxide Delivery Device Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hypoxic Respiratory Failure (HRF) Image Figure 9. Chronic Obstructive Pulmonary Disease (COPD) Image Figure 10. Acute Hypoxemic Respiratory Failure (AHRF) Image Figure 11. Others Image Figure 12. Global Inhaled Nitric Oxide Delivery Device Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Inhaled Nitric Oxide Delivery Device Revenue (2021-2032) & (US$ Million) Figure 14. Global Inhaled Nitric Oxide Delivery Device Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Region (2021-2032) Figure 17. Global Inhaled Nitric Oxide Delivery Device Sales (2021-2032) & (k units) Figure 18. Global Inhaled Nitric Oxide Delivery Device Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 19. Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Inhaled Nitric Oxide Delivery Device Sales YoY (2021-2032) & (k units) Figure 21. Europe Inhaled Nitric Oxide Delivery Device Sales YoY (2021-2032) & (k units) Figure 22. China Inhaled Nitric Oxide Delivery Device Sales YoY (2021-2032) & (k units) Figure 23. Asia (Excluding China) Inhaled Nitric Oxide Delivery Device Sales YoY (2021-2032) & (k units) Figure 24. South America, Middle East and Africa Inhaled Nitric Oxide Delivery Device Sales YoY (2021-2032) & (k units) Figure 25. Global Inhaled Nitric Oxide Delivery Device Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Inhaled Nitric Oxide Delivery Device Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Inhaled Nitric Oxide Delivery Device Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Type (2021-2032) Figure 31. Global Inhaled Nitric Oxide Delivery Device Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 32. Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Type (2021-2032) Figure 34. Global Inhaled Nitric Oxide Delivery Device Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Application (2021-2032) Figure 37. Global Inhaled Nitric Oxide Delivery Device Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 38. Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Application (2021-2032) Figure 40. North America Inhaled Nitric Oxide Delivery Device Revenue Share by Type (2021-2032) Figure 41. North America Inhaled Nitric Oxide Delivery Device Sales Share by Type (2021-2032) Figure 42. North America Inhaled Nitric Oxide Delivery Device Revenue Share by Application (2021-2032) Figure 43. North America Inhaled Nitric Oxide Delivery Device Sales Share by Application (2021-2032) Figure 44. North America Inhaled Nitric Oxide Delivery Device Revenue Share by Country (2021-2032) Figure 45. North America Inhaled Nitric Oxide Delivery Device Sales Share by Country (2021-2032) Figure 46. Europe Inhaled Nitric Oxide Delivery Device Revenue Share by Type (2021-2032) Figure 47. Europe Inhaled Nitric Oxide Delivery Device Sales Share by Type (2021-2032) Figure 48. Europe Inhaled Nitric Oxide Delivery Device Revenue Share by Application (2021-2032) Figure 49. Europe Inhaled Nitric Oxide Delivery Device Sales Share by Application (2021-2032) Figure 50. Europe Inhaled Nitric Oxide Delivery Device Revenue Share by Country (2021-2032) Figure 51. Europe Inhaled Nitric Oxide Delivery Device Sales Share by Country (2021-2032) Figure 52. China Inhaled Nitric Oxide Delivery Device Revenue Share by Type (2021-2032) Figure 53. China Inhaled Nitric Oxide Delivery Device Sales Share by Type (2021-2032) Figure 54. China Inhaled Nitric Oxide Delivery Device Revenue Share by Application (2021-2032) Figure 55. China Inhaled Nitric Oxide Delivery Device Sales Share by Application (2021-2032) Figure 56. Asia Inhaled Nitric Oxide Delivery Device Revenue Share by Type (2021-2032) Figure 57. Asia Inhaled Nitric Oxide Delivery Device Sales Share by Type (2021-2032) Figure 58. Asia Inhaled Nitric Oxide Delivery Device Revenue Share by Application (2021-2032) Figure 59. Asia Inhaled Nitric Oxide Delivery Device Sales Share by Application (2021-2032) Figure 60. Asia Inhaled Nitric Oxide Delivery Device Revenue Share by Country (2021-2032) Figure 61. Asia Inhaled Nitric Oxide Delivery Device Sales Share by Country (2021-2032) Figure 62. SAMEA Inhaled Nitric Oxide Delivery Device Revenue Share by Type (2021-2032) Figure 63. SAMEA Inhaled Nitric Oxide Delivery Device Sales Share by Type (2021-2032) Figure 64. SAMEA Inhaled Nitric Oxide Delivery Device Revenue Share by Application (2021-2032) Figure 65. SAMEA Inhaled Nitric Oxide Delivery Device Sales Share by Application (2021-2032) Figure 66. SAMEA Inhaled Nitric Oxide Delivery Device Revenue Share by Country (2021-2032) Figure 67. SAMEA Inhaled Nitric Oxide Delivery Device Sales Share by Country (2021-2032) Figure 68. Inhaled Nitric Oxide Delivery Device Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Inhaled Nitric Oxide Delivery Device Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Inhaled Nitric Oxide Delivery Device for Children
  • Inhaled Nitric Oxide Delivery Device for Adults
Applications
  • Hypoxic Respiratory Failure (HRF)
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Acute Hypoxemic Respiratory Failure (AHRF)
  • Others
Companies covered
  • Air Liquide Healthcare
  • Bellerophon Therapeutics
  • Beyond Air
  • Circassia Pharmaceuticals
  • Getinge
  • LINDE
  • Mallinckrodt Pharmaceuticals
  • NU MED
  • Praxair Technology Inc.
  • Vero Biotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Inhaled Nitric Oxide Delivery Device Market by Type
  3. 1.2.1 Global Inhaled Nitric Oxide Delivery Device Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Inhaled Nitric Oxide Delivery Device for Children
  5. 1.2.3 Inhaled Nitric Oxide Delivery Device for Adults
  6. 1.3 Inhaled Nitric Oxide Delivery Device Market by Application
  7. 1.3.1 Global Inhaled Nitric Oxide Delivery Device Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hypoxic Respiratory Failure (HRF)
  9. 1.3.3 Chronic Obstructive Pulmonary Disease (COPD)
  10. 1.3.4 Acute Hypoxemic Respiratory Failure (AHRF)
  11. 1.3.5 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Inhaled Nitric Oxide Delivery Device Market Dynamics
  1. 2.1 Inhaled Nitric Oxide Delivery Device Industry Trends
  2. 2.2 Inhaled Nitric Oxide Delivery Device Industry Drivers
  3. 2.3 Inhaled Nitric Oxide Delivery Device Industry Opportunities and Challenges
  4. 2.4 Inhaled Nitric Oxide Delivery Device Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Inhaled Nitric Oxide Delivery Device Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Inhaled Nitric Oxide Delivery Device Revenue by Region
  3. 3.2.1 Global Inhaled Nitric Oxide Delivery Device Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Inhaled Nitric Oxide Delivery Device Revenue by Region (2021-2026)
  5. 3.2.3 Global Inhaled Nitric Oxide Delivery Device Revenue by Region (2027-2032)
  6. 3.2.4 Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Inhaled Nitric Oxide Delivery Device Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Inhaled Nitric Oxide Delivery Device Sales by Region
  9. 3.4.1 Global Inhaled Nitric Oxide Delivery Device Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Inhaled Nitric Oxide Delivery Device Sales by Region (2021-2026)
  11. 3.4.3 Global Inhaled Nitric Oxide Delivery Device Sales by Region (2027-2032)
  12. 3.4.4 Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Inhaled Nitric Oxide Delivery Device Revenue by Manufacturers
  2. 4.1.1 Global Inhaled Nitric Oxide Delivery Device Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Inhaled Nitric Oxide Delivery Device Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Inhaled Nitric Oxide Delivery Device Sales by Manufacturers
  6. 4.2.1 Global Inhaled Nitric Oxide Delivery Device Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Inhaled Nitric Oxide Delivery Device Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Inhaled Nitric Oxide Delivery Device Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Inhaled Nitric Oxide Delivery Device Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Inhaled Nitric Oxide Delivery Device Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Inhaled Nitric Oxide Delivery Device Manufacturers, Product Type & Application
  13. 4.7 Global Inhaled Nitric Oxide Delivery Device Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Inhaled Nitric Oxide Delivery Device Market CR5 and HHI
  16. 4.8.2 2025 Inhaled Nitric Oxide Delivery Device Tier 1, Tier 2, and Tier 3
5 Inhaled Nitric Oxide Delivery Device Market by Type
  1. 5.1 Global Inhaled Nitric Oxide Delivery Device Revenue by Type
  2. 5.1.1 Global Inhaled Nitric Oxide Delivery Device Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Inhaled Nitric Oxide Delivery Device Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Inhaled Nitric Oxide Delivery Device Sales by Type
  6. 5.2.1 Global Inhaled Nitric Oxide Delivery Device Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Inhaled Nitric Oxide Delivery Device Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Type (2021-2032)
  9. 5.3 Global Inhaled Nitric Oxide Delivery Device Price by Type
6 Inhaled Nitric Oxide Delivery Device Market by Application
  1. 6.1 Global Inhaled Nitric Oxide Delivery Device Revenue by Application
  2. 6.1.1 Global Inhaled Nitric Oxide Delivery Device Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Inhaled Nitric Oxide Delivery Device Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Inhaled Nitric Oxide Delivery Device Sales by Application
  6. 6.2.1 Global Inhaled Nitric Oxide Delivery Device Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Inhaled Nitric Oxide Delivery Device Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Application (2021-2032)
  9. 6.3 Global Inhaled Nitric Oxide Delivery Device Price by Application
7 Company Profiles
  1. 7.1 Air Liquide Healthcare
  2. 7.1.1 Air Liquide Healthcare Company Information
  3. 7.1.2 Air Liquide Healthcare Business Overview
  4. 7.1.3 Air Liquide Healthcare Inhaled Nitric Oxide Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Air Liquide Healthcare Inhaled Nitric Oxide Delivery Device Product Portfolio
  6. 7.1.5 Air Liquide Healthcare Recent Developments
  7. 7.2 Bellerophon Therapeutics
  8. 7.2.1 Bellerophon Therapeutics Company Information
  9. 7.2.2 Bellerophon Therapeutics Business Overview
  10. 7.2.3 Bellerophon Therapeutics Inhaled Nitric Oxide Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Bellerophon Therapeutics Inhaled Nitric Oxide Delivery Device Product Portfolio
  12. 7.2.5 Bellerophon Therapeutics Recent Developments
  13. 7.3 Beyond Air
  14. 7.3.1 Beyond Air Company Information
  15. 7.3.2 Beyond Air Business Overview
  16. 7.3.3 Beyond Air Inhaled Nitric Oxide Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Beyond Air Inhaled Nitric Oxide Delivery Device Product Portfolio
  18. 7.3.5 Beyond Air Recent Developments
  19. 7.4 Circassia Pharmaceuticals
  20. 7.4.1 Circassia Pharmaceuticals Company Information
  21. 7.4.2 Circassia Pharmaceuticals Business Overview
  22. 7.4.3 Circassia Pharmaceuticals Inhaled Nitric Oxide Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Circassia Pharmaceuticals Inhaled Nitric Oxide Delivery Device Product Portfolio
  24. 7.4.5 Circassia Pharmaceuticals Recent Developments
  25. 7.5 Getinge
  26. 7.5.1 Getinge Company Information
  27. 7.5.2 Getinge Business Overview
  28. 7.5.3 Getinge Inhaled Nitric Oxide Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Getinge Inhaled Nitric Oxide Delivery Device Product Portfolio
  30. 7.5.5 Getinge Recent Developments
  31. 7.6 LINDE
  32. 7.6.1 LINDE Company Information
  33. 7.6.2 LINDE Business Overview
  34. 7.6.3 LINDE Inhaled Nitric Oxide Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 LINDE Inhaled Nitric Oxide Delivery Device Product Portfolio
  36. 7.6.5 LINDE Recent Developments
  37. 7.7 Mallinckrodt Pharmaceuticals
  38. 7.7.1 Mallinckrodt Pharmaceuticals Company Information
  39. 7.7.2 Mallinckrodt Pharmaceuticals Business Overview
  40. 7.7.3 Mallinckrodt Pharmaceuticals Inhaled Nitric Oxide Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Mallinckrodt Pharmaceuticals Inhaled Nitric Oxide Delivery Device Product Portfolio
  42. 7.7.5 Mallinckrodt Pharmaceuticals Recent Developments
  43. 7.8 NU MED
  44. 7.8.1 NU MED Company Information
  45. 7.8.2 NU MED Business Overview
  46. 7.8.3 NU MED Inhaled Nitric Oxide Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 NU MED Inhaled Nitric Oxide Delivery Device Product Portfolio
  48. 7.8.5 NU MED Recent Developments
  49. 7.9 Praxair Technology Inc.
  50. 7.9.1 Praxair Technology Inc. Company Information
  51. 7.9.2 Praxair Technology Inc. Business Overview
  52. 7.9.3 Praxair Technology Inc. Inhaled Nitric Oxide Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Praxair Technology Inc. Inhaled Nitric Oxide Delivery Device Product Portfolio
  54. 7.9.5 Praxair Technology Inc. Recent Developments
  55. 7.10 Vero Biotech
  56. 7.10.1 Vero Biotech Company Information
  57. 7.10.2 Vero Biotech Business Overview
  58. 7.10.3 Vero Biotech Inhaled Nitric Oxide Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Vero Biotech Inhaled Nitric Oxide Delivery Device Product Portfolio
  60. 7.10.5 Vero Biotech Recent Developments
8 North America
  1. 8.1 North America Inhaled Nitric Oxide Delivery Device Market Size by Type
  2. 8.1.1 North America Inhaled Nitric Oxide Delivery Device Revenue by Type (2021-2032)
  3. 8.1.2 North America Inhaled Nitric Oxide Delivery Device Sales by Type (2021-2032)
  4. 8.1.3 North America Inhaled Nitric Oxide Delivery Device Price by Type (2021-2032)
  5. 8.2 North America Inhaled Nitric Oxide Delivery Device Market Size by Application
  6. 8.2.1 North America Inhaled Nitric Oxide Delivery Device Revenue by Application (2021-2032)
  7. 8.2.2 North America Inhaled Nitric Oxide Delivery Device Sales by Application (2021-2032)
  8. 8.2.3 North America Inhaled Nitric Oxide Delivery Device Price by Application (2021-2032)
  9. 8.3 North America Inhaled Nitric Oxide Delivery Device Market Size by Country
  10. 8.3.1 North America Inhaled Nitric Oxide Delivery Device Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Inhaled Nitric Oxide Delivery Device Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Inhaled Nitric Oxide Delivery Device Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Inhaled Nitric Oxide Delivery Device Market Size by Type
  2. 9.1.1 Europe Inhaled Nitric Oxide Delivery Device Revenue by Type (2021-2032)
  3. 9.1.2 Europe Inhaled Nitric Oxide Delivery Device Sales by Type (2021-2032)
  4. 9.1.3 Europe Inhaled Nitric Oxide Delivery Device Price by Type (2021-2032)
  5. 9.2 Europe Inhaled Nitric Oxide Delivery Device Market Size by Application
  6. 9.2.1 Europe Inhaled Nitric Oxide Delivery Device Revenue by Application (2021-2032)
  7. 9.2.2 Europe Inhaled Nitric Oxide Delivery Device Sales by Application (2021-2032)
  8. 9.2.3 Europe Inhaled Nitric Oxide Delivery Device Price by Application (2021-2032)
  9. 9.3 Europe Inhaled Nitric Oxide Delivery Device Market Size by Country
  10. 9.3.1 Europe Inhaled Nitric Oxide Delivery Device Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Inhaled Nitric Oxide Delivery Device Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Inhaled Nitric Oxide Delivery Device Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Inhaled Nitric Oxide Delivery Device Market Size by Type
  2. 10.1.1 China Inhaled Nitric Oxide Delivery Device Revenue by Type (2021-2032)
  3. 10.1.2 China Inhaled Nitric Oxide Delivery Device Sales by Type (2021-2032)
  4. 10.1.3 China Inhaled Nitric Oxide Delivery Device Price by Type (2021-2032)
  5. 10.2 China Inhaled Nitric Oxide Delivery Device Market Size by Application
  6. 10.2.1 China Inhaled Nitric Oxide Delivery Device Revenue by Application (2021-2032)
  7. 10.2.2 China Inhaled Nitric Oxide Delivery Device Sales by Application (2021-2032)
  8. 10.2.3 China Inhaled Nitric Oxide Delivery Device Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Inhaled Nitric Oxide Delivery Device Market Size by Type
  2. 11.1.1 Asia Inhaled Nitric Oxide Delivery Device Revenue by Type (2021-2032)
  3. 11.1.2 Asia Inhaled Nitric Oxide Delivery Device Sales by Type (2021-2032)
  4. 11.1.3 Asia Inhaled Nitric Oxide Delivery Device Price by Type (2021-2032)
  5. 11.2 Asia Inhaled Nitric Oxide Delivery Device Market Size by Application
  6. 11.2.1 Asia Inhaled Nitric Oxide Delivery Device Revenue by Application (2021-2032)
  7. 11.2.2 Asia Inhaled Nitric Oxide Delivery Device Sales by Application (2021-2032)
  8. 11.2.3 Asia Inhaled Nitric Oxide Delivery Device Price by Application (2021-2032)
  9. 11.3 Asia Inhaled Nitric Oxide Delivery Device Market Size by Country
  10. 11.3.1 Asia Inhaled Nitric Oxide Delivery Device Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Inhaled Nitric Oxide Delivery Device Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Inhaled Nitric Oxide Delivery Device Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Inhaled Nitric Oxide Delivery Device Market Size by Type
  2. 12.1.1 SAMEA Inhaled Nitric Oxide Delivery Device Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Inhaled Nitric Oxide Delivery Device Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Inhaled Nitric Oxide Delivery Device Price by Type (2021-2032)
  5. 12.2 SAMEA Inhaled Nitric Oxide Delivery Device Market Size by Application
  6. 12.2.1 SAMEA Inhaled Nitric Oxide Delivery Device Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Inhaled Nitric Oxide Delivery Device Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Inhaled Nitric Oxide Delivery Device Price by Application (2021-2032)
  9. 12.3 SAMEA Inhaled Nitric Oxide Delivery Device Market Size by Country
  10. 12.3.1 SAMEA Inhaled Nitric Oxide Delivery Device Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Inhaled Nitric Oxide Delivery Device Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Inhaled Nitric Oxide Delivery Device Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Inhaled Nitric Oxide Delivery Device Value Chain Analysis
  2. 13.1.1 Inhaled Nitric Oxide Delivery Device Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Inhaled Nitric Oxide Delivery Device Production Mode & Process
  6. 13.2 Inhaled Nitric Oxide Delivery Device Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Inhaled Nitric Oxide Delivery Device Distributors
  9. 13.2.3 Inhaled Nitric Oxide Delivery Device Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research